The study uses a mixed method study to evaluate wether the use of the indicators of the Quality of end-of-life cancer care, developed by Earle et al \[Earle JCO 2003; DOI: 10.1200/JCO.2003.03.059\] would be relevant and measurable in France. The qualitative part of study was designed to investigate the representations of quality by face-to face interviews with family carer of recently deceased cancer patients, and with their oncologists, and nurses. The quantitative part of the study, consisted in a decedents case series analysis, diagnosed with advanced cancer and followed up in 5 centers. Data on trajectory of care were collected from different complementary sources associating national mortality data, hospital activity data, and health records. The study was approved by the French data protection authority (CNIL) number 611273.
Study Type
OBSERVATIONAL
Enrollment
997
APHP Hôpital Cochin
Paris, France
APHP Hôpital Européen Georges Pompidou
Paris, France
APHP Hôpital Henri Mondor
Paris, France
Institut Gustave Roussy
Villejuif, France
Institut Curie
Paris, Île-de-France Region, France
Use of emergency services within last 30 days before death
Time frame: Through study completion, up to 1 year
Patients received chemotherapy in the last 14 days of life
Time frame: Through study completion, up to 1 year
Location of death
Time frame: Through study completion, up to 1 year
Among patients who died in palliative care unit, those who died within 3 days after admission
Time frame: Through study completion, up to 1 year
Admission in intensive care unit within last 30 days before death
Time frame: Through study completion, up to 1 year
Among patients with pain relief opioid treatment, those with combined short term and long acting opioid orders
Time frame: Through study completion, up to 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.